Retatrutide has attracted considerable attention in discussions about weight management, metabolic health, and medical research. Developed by Eli Lilly, it is an investigational medication designed to activate three hormone receptors: GIP, GLP-1, and glucagon. This triple-action approach has made it an important subject of clinical research, particularly among scientists exploring new... https://retatrutidecosts.com/